Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (2): 172-180.doi: 10.19982/j.issn.1000-6621.20220274
• Original Articles • Previous Articles Next Articles
Yang Hong1, Ma Jinbao1, Ren Fei1(), Li Rong1, Wu Yanqin1, Zhang Yaohui2
Received:
2022-12-20
Online:
2023-02-10
Published:
2023-02-01
Contact:
Ren Fei
E-mail:doc.renfei@163.com
Supported by:
CLC Number:
Yang Hong, Ma Jinbao, Ren Fei, Li Rong, Wu Yanqin, Zhang Yaohui. Analysis of clinical characteristics of 15 household contacts of patients with drug-resistant pulmonary tuberculosis who developed active pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 172-180. doi: 10.19982/j.issn.1000-6621.20220274
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220274
患者编号 | 性别 | 年龄 (岁) | 与指示 病例关系 | 结核病 治疗史 | 接触场所 通风情况 | 卡介苗 接种史 | 接触到发病 时间间隔(月) |
---|---|---|---|---|---|---|---|
病例1 | 女性 | 52 | 妻子 | 无 | 不良 | 无 | 11.0 |
病例2 | 女性 | 31 | 妹妹 | 无 | 一般 | 有 | 9.0 |
病例3 | 男性 | 51 | 丈夫 | 无 | 不良 | 无 | 9.0 |
病例4 | 女性 | 33 | 妻子 | 无 | 不良 | 有 | 11.0 |
病例5 | 女性 | 56 | 母亲 | 无 | 不良 | 无 | 3.0 |
病例6 | 女性 | 43 | 妻子 | 无 | 一般 | 无 | 0.5 |
病例7 | 女性 | 45 | 母亲 | 无 | 一般 | 无 | 1.0 |
病例8 | 女性 | 24 | 女儿 | 无 | 不良 | 有 | 1.0 |
病例9 | 女性 | 31 | 女儿 | 无 | 不良 | 无 | 2.0 |
病例10 | 男性 | 32 | 女婿 | 无 | 不良 | 无 | 1.5 |
病例11 | 女性 | 30 | 儿媳 | 无 | 良好 | 有 | 1.0 |
病例12 | 女性 | 29 | 妻子 | 无 | 良好 | 有 | 0.5 |
病例13 | 男性 | 3 | 儿子 | 无 | 一般 | 有 | 7.0 |
病例14 | 女性 | 34 | 妻子 | 无 | 良好 | 有 | 6.0 |
病例15 | 男性 | 47 | 父亲 | 无 | 不良 | 无 | 12.0 |
临床特点 | 指示病例(15例) | 罹患病例(15例) | χ2值 | P值 | ||
---|---|---|---|---|---|---|
性别 | 4.821 | 0.028 | ||||
男性 | 10(66.7) | 4(26.7) | ||||
女性 | 5(33.3) | 11(73.3) | ||||
年龄组(岁) | 1.598 | 0.891 | ||||
0~14 | 1(6.7) | 1(6.7) | ||||
15~24 | 1(6.7) | 1(6.7) | ||||
25~54 | 10(66.7) | 12(80.0) | ||||
≥55 | 3(20.0) | 1(6.7) | ||||
与指示病例的关系 | - | - | ||||
父母 | - | 3(20.0) | ||||
子女 | - | 3(20.0) | ||||
配偶 | - | 6(40.0) | ||||
妹妹 | - | 1(6.7) | ||||
儿媳 | - | 1(6.7) | ||||
女婿 | - | 1(6.7) | ||||
抗结核治疗史 | 15.000 | <0.001 | ||||
有 | 10(66.7) | 0(0.0) | ||||
无 | 5(33.3) | 15(100.0) | ||||
接触到发病时间(月)a | - | - | ||||
0~1 | - | 2(13.3) | ||||
1~2 | - | 4(26.7) | ||||
2~6 | - | 2(13.3) | ||||
6~12 | - | 6(40.0) | ||||
≥12 | - | 1(6.7) | ||||
PPD皮肤试验 | - | - | ||||
未做 | - | 3(20.0) | ||||
阴性 | - | 1(6.7) | ||||
一般阳性 | - | 0(0.0) | ||||
中度阳性 | - | 2(13.3) | ||||
强阳性 | - | 9(60.0) | ||||
T-SPOT.TB检测结果 | - | - | ||||
阴性 | - | 3(20.0) | ||||
阳性 | - | 10(66.7) | ||||
未做 | - | 2(13.3) | ||||
痰涂片检查抗酸杆菌 | 11.620 | 0.009 | ||||
阴性 | 5(33.3) | 13(86.6) | ||||
阳性 | 4(26.7) | 1(6.7) | ||||
+ | 3(20.0) | 1(6.7) | ||||
++~++++ | 3(20.0) | 0(0.0) | ||||
痰结核分枝杆菌培养 | 9.130 | 0.003 | ||||
阴性 | 0(0.0) | 7(46.7) | ||||
阳性 | 15(100.0) | 8(53.3) | ||||
临床特点 | 指示病例(15例) | 罹患病例(15例) | χ2值 | P值 | ||
影像学检查病灶肺野数 | 6.000 | 0.014 | ||||
1~3 | 10(66.7) | 15(100.0) | ||||
4~6 | 5(33.3) | 0(0.0) | ||||
是否有空洞 | 3.394 | 0.065 | ||||
有 | 9(60.0) | 4(26.7) | ||||
无 | 6(40.0) | 11(73.3) | ||||
就诊原因 | - | - | ||||
因症就诊 | - | 7(46.7) | ||||
主动筛查 | - | 8(53.3) |
分类 | 指示病例 | 罹患病例 | ||
---|---|---|---|---|
例数 | 构成比(%) | 例数 | 构成比(%) | |
病原学结果 | ||||
阳性 | 15 | 100.0 | 9 | 60.0 |
阴性 | 0 | 0.0 | 6 | 40.0 |
表型药敏试验结果 | ||||
耐多药 | 11 | 73.3 | 8 | 53.3 |
单耐药 | 4 | 26.7 | 1 | 6.7 |
未知 | 0 | 0.0 | 6 | 40.0 |
痰分子药敏试验结果 | ||||
耐药 | - | - | 6 | 40.0 |
敏感 | - | - | 0 | 0.0 |
未做 | - | - | 9 | 60.0 |
与指示病例药敏试验结果是否一致 | ||||
是 | - | - | 9 | 60.0 |
未知 | - | - | 6 | 40.0 |
结核病类别 | ||||
肺结核 | 9 | 60.0 | 13 | 86.6 |
肺外结核 | 0 | 0.0 | 1 | 6.7 |
肺结核合并肺外结核 | 6 | 40.0 | 1 | 6.7 |
治疗结局 | ||||
治愈 | 7 | 46.6 | 11 | 73.4 |
强化期末细菌学阴转 | 4 | 26.7 | 2 | 13.3 |
失败 | 4 | 26.7 | 0 | 0.0 |
丢失 | 0 | 0.0 | 2 | 13.3 |
[1] |
张家泳, 丛守婧, 王涛, 等. 中国肺结核患者家庭密切接触者活动性肺结核检出情况的Meta分析. 中国防痨杂志, 2016, 38(10): 862-868. doi:10.3969/j.issn.1000-6621.2016.10.015.
doi: 10.3969/j.issn.1000-6621.2016.10.015 |
[2] |
Becerra MC, Appleton SC, Franke MF, et al. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet, 2011, 377(9760): 147-152. doi:10.1016/S0140-6736(10)61972-1.
doi: 10.1016/S0140-6736(10)61972-1 pmid: 21145581 |
[3] |
Shadrach BJ, Kumar S, Deokar K, et al. A study of multidrug resistant tuberculosis among symptomatic household contacts of MDR-TB patients. Indian J Tuberc, 2021, 68(1): 25-31. doi:10.1016/j.ijtb.2020.09.030.
doi: 10.1016/j.ijtb.2020.09.030 URL |
[4] |
Conceição EC, Guimarães AEDS, Lopes ML, et al. Analysis of potential household transmission events of tuberculosis in the city of Belem, Brazil. Tuberculosis (Edinb), 2018, 113: 125-129. doi:10.1016/j.tube.2018.09.011.
doi: 10.1016/j.tube.2018.09.011 URL |
[5] | World Health Organization. Recommendations for Investigating Contacts of Persons with Infectious Tuberculosis in Low- and Middle-Income Countries. Geneva: World Health Organization, 2012. |
[6] |
Uplekar M, Weil D, Lonnroth K, et al. WHO’s new end TB strategy. Lancet, 2015, 385(9979): 1799-1801. doi:10.1016/S0140-6736(15)60570-0.
doi: S0140-6736(15)60570-0 pmid: 25814376 |
[7] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[8] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 2017-11-09. |
[9] |
中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019, 41 (10): 1025-1073. doi:10.3969/j.issn.1000-6621.2019.10.001.
doi: 10.3969/j.issn.1000-6621.2019.10.001 |
[10] |
Sterling TR, Njie G, Zenner D, et al. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep, 2020, 69(1): 1-11. doi:10.15585/mmwr.rr690lal.
doi: 10.15585/mmwr.rr690lal |
[11] |
Chen J, Chen L, Zhou M, et al. Transmission of multidrug-resistant tuberculosis within family households by DTM-PCR and MIRU-VNTR genotyping. BMC Infect Dis, 2022, 22(1): 192. doi:10.1186/s12879-022-07188-7.
doi: 10.1186/s12879-022-07188-7 pmid: 35219320 |
[12] |
Reichler MR, Khan A, Sterling TR, et al. Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis. J Infect Dis, 2018, 218(6): 1000-1008. doi:10.1093/infdis/jiy265.
doi: 10.1093/infdis/jiy265 pmid: 29767733 |
[13] | 王崇恩. 民用建筑设计统一标准. 北京: 中国建筑工业出版社, 2019. |
[14] | 中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 中华人民共和国教育部, 等. 卫生健康委发展改革委教育部科技部民政部财政部扶贫办医保局关于印发遏制结核病行动计(2019—2022年)的通知. 国卫疾控发﹝2019﹞41号. 2019-05-31. |
[15] | Long R, Schwartzman K. Pathogenesis and transmission of tuberculosis. Vancouver: Canadian Thoracic Society, Canadian Lung Association Public Health Agency of Canada, 2014. |
[16] |
Guo J, Yang M, Wu Z, et al. High incidence and low case detection rate among contacts of tuberculosis cases in Shanghai, China. BMC Infect Dis, 2019, 19(1): 320. doi:10.1186/s12879-019-3942-2.
doi: 10.1186/s12879-019-3942-2 pmid: 30975088 |
[17] |
Javaid A, Khan MA, Khan MA, et al. Screening outcomes of household contacts of multidrug-resistant tuberculosis patients in Peshawar, Pakistan. Asian Pac J Trop Med, 2016, 9(9): 909-912. doi:10.1016/j.apjtm.2016.07.017.
doi: S1995-7645(16)30154-7 pmid: 27633308 |
[18] |
Baliashvili D, Kempker RR, Blumberg HM, et al. A population-based tuberculosis contact investigation in the country of Georgia. Public Health Action, 2018, 8(3): 110-117. doi:10.5588/pha.18.0024.
doi: 10.5588/pha.18.0024 pmid: 30271726 |
[19] |
Becerra MC, Huang CC, Lecca L, et al. Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study. BMJ, 2019, 367: 15894. doi:10.1136/bmj.l5894.
doi: 10.1136/bmj.l5894 |
[20] |
Moore DA. What can we offer to 3 million MDRTB household contacts in 2016? BMC Med, 2016, 14: 64. doi:10.1186/s12916-016-0610-x.
doi: 10.1186/s12916-016-0610-x |
[21] |
Kigozi NG, Heunis JC, Engelbrecht MC. Yield of systematic household contact investigation for tuberculosis in a high-burden metropolitan district of South Africa. BMC Public Health, 2019, 19(1): 867. doi:10.1186/s12889-019-7194-2.
doi: 10.1186/s12889-019-7194-2 pmid: 31269950 |
[22] |
Fox GJ, Barry SE, Britton WJ, et al. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2013, 41(1): 140-156. doi:10.1183/09031936.00070812.
doi: 10.1183/09031936.00070812 pmid: 22936710 |
[23] |
Shah NS, Yuen CM, Heo M, et al. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis, 2014, 58(3): 381-391. doi:10.1093/cid/cit643.
doi: 10.1093/cid/cit643 pmid: 24065336 |
[24] |
Bartu V. Importance of TB contact investigations. Respir Med Case Rep, 2016, 18: 87-89. doi:10.1016/j.rmcr.2016.05.001.
doi: 10.1016/j.rmcr.2016.05.001 pmid: 27330961 |
[25] |
Jerene D, Melese M, Kassie Y, et al. The yield of a tuberculosis household contact investigation in two regions of Ethiopia. Int J Tuberc Lung Dis, 2015, 19(8): 898-903. doi:10.5588/ijtld.14.0978.
doi: 10.5588/ijtld.14.0978 pmid: 26162354 |
[26] |
Teixeira L, Perkins MD, Johnson JL, et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 2001, 5(4): 321-328.
pmid: 11334250 |
[27] |
Grandjean L, Crossa A, Gilman RH, et al. Tuberculosis in household contacts of multidrug-resistant tuberculosis patients. Int J Tuberc Lung Dis, 2011, 15(9): 1164-1169. doi:10.5588/ijtld.11.0030.
doi: 10.5588/ijtld.11.0030 pmid: 21943839 |
[1] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[2] | Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng. Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273. |
[3] | Yang Ziyi, Chen Suting. Research progress on bedaquiline resistance and drug resistance diagnosis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 374-379. |
[4] | Li Xuelian, Zhang Hongyan, Wang Jun, Wang Qingfeng, Ma Liping, Chu Naihui, Nie Wenjuan. Safety of extended delamanid use in drug-resistant tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 164-168. |
[5] | Xu Zian, Pu Feifei, Feng Jing, Xia Ping. Research progress of high-throughput sequencing technology in the diagnosis and treatment of osteoarticular tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 224-230. |
[6] | Geng Zimei, Wang Chaohong, Long Sibo, Zheng Maike, Shi Yiheng, Sun Yong, Zhao Yan, Wang Guirong. Analysis of bacteriological positivity and rifampicin resistance in patients with severe pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1050-1055. |
[7] | Wang Fei, Hua Duo, Guo Jianjian, Liu Chang, Han Lu, Ren Yi. Characteristic analysis of non-tuberculous mycobacterial pulmonary disease patients in Wuhan area from 2021 to 2023 [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1069-1076. |
[8] | Yang Liangzi, Zhang Peize, Lu Shuihua. Interpretation of World Health Organization’s Co-administration of Treatment for Drug-resistant Tuberculosis and Hepatitis C: 2024 Update [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 874-876. |
[9] | Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong. Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896. |
[10] | Xu Chunhua, Zhu Shiyu, Hu Yi, Yi Kehua, Song Canlei, Wang Zichun, Wu Yong, Wang Qing, Yang Qianru, Shen Xin. Analysis of screening effect of recombinant Mycobacterium tuberculosis fusion protein in screening Mycobacterium tuberculosis infection in close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 897-902. |
[11] | Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei. Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950. |
[12] | Gao Lei, Liang Yaxue, Liu Shengsheng, Wang Hua. Analysis of treatment outcomes and influencing factors in 144 elderly patients with rifampicin drug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 799-807. |
[13] | Zhang Hongtai, Ren Yixuan, Hu peilei, Wang Nenhan, Li Jie, Tian Lili, Zhao Yanfeng, Chen Shuangshuang, Li Chuanyou. Comparison of microbiota diversity in the sputum of pulmonary tuberculosis patients with rifampicin resistance or sensitivity [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 625-633. |
[14] | Du Yuhua, Feng Yajuan, Lei Yu, Lai Keng, He Weiyun. Analysis of the detection and treatment of rifampicin-resistant pulmonary tuberculosis patients in Guangzhou during the “12th Five-Year Plan” and “13th Five-Year Plan” periods [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 678-686. |
[15] | Ye Xinchun, Liu Saiduo, Cheng Fang, Jiang Xiangao, Ning Hongye, Wu Zhengxing, Zhou Yueying, Qiu Chaochao, Pan Ning, Shi Jichan. Risk factors of latent tuberculosis infection among close contacts of drug-resistant pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(5): 525-530. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||